Total Payments
$312.55
2024 Payments
$36.61
Companies
9
Transactions
16
Medicare Patients
2,033
Medicare Billing
$273,381
Payment Breakdown by Category
Food & Beverage$312.55 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $312.55 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $55.25 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $46.17 | 3 | $0 (2017) |
| Merz North America, Inc. | $42.75 | 1 | $0 (2019) |
| Genentech USA, Inc. | $36.30 | 2 | $0 (2017) |
| LEO Pharma Inc. | $34.95 | 2 | $0 (2017) |
| PFIZER INC. | $29.70 | 2 | $0 (2022) |
| Galderma Laboratories, L.P. | $29.02 | 2 | $0 (2017) |
| Lilly USA, LLC | $26.98 | 1 | $0 (2022) |
| Biofrontera Inc. | $11.43 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36.61 | 1 | Regeneron Healthcare Solutions, Inc. ($36.61) |
| 2022 | $41.48 | 2 | Lilly USA, LLC ($26.98) |
| 2019 | $42.75 | 1 | Merz North America, Inc. ($42.75) |
| 2018 | $18.64 | 1 | Regeneron Healthcare Solutions, Inc. ($18.64) |
| 2017 | $173.07 | 11 | GlaxoSmithKline, LLC. ($46.17) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: DERMATOLOGY | ||||||
| 10/25/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Immunology | ||||||
| 11/20/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $42.75 | General |
| Category: DERMATOLOGY | ||||||
| 01/26/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/21/2017 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Immunology | ||||||
| 09/20/2017 | Galderma Laboratories, L.P. | ORACEA (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: ROSACEA | ||||||
| 09/13/2017 | Galderma Laboratories, L.P. | ORACEA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: ROSACEA | ||||||
| 09/12/2017 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Food and Beverage | Cash or cash equivalent | $11.43 | General |
| Category: Dermatology | ||||||
| 09/07/2017 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: BioOncology | ||||||
| 09/07/2017 | GlaxoSmithKline, LLC. | BREO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2017 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: DERMATOLOGY | ||||||
| 04/05/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: RESPIRATORY | ||||||
| 03/18/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: DERMATOLOGY | ||||||
| 02/15/2017 | LEO Pharma Inc. | PICATO (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: DERMATOLOGY | ||||||
| 01/18/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 146 | 180 | $139,466 | $60,582 |
| 2021 | 14 | 659 | 805 | $122,557 | $71,075 |
| 2020 | 21 | 1,228 | 1,612 | $237,082 | $141,723 |
Total Patients
2,033
Total Services
2,597
Medicare Billing
$273,381
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 61 | 81 | $81,559 | $36,003 | 44.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 28 | 40 | $24,332 | $12,400 | 51.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 12 | 13 | $12,236 | $6,149 | 50.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 20 | 20 | $9,001 | $3,058 | 34.0% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 25 | 26 | $12,337 | $2,972 | 24.1% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 48 | 53 | $36,770 | $24,645 | 67.0% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2021 | 24 | 36 | $15,300 | $11,620 | 76.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 189 | 247 | $17,435 | $8,423 | 48.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 80 | 83 | $9,975 | $5,674 | 56.9% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 62 | 68 | $10,200 | $5,659 | 55.5% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 74 | 74 | $7,010 | $3,117 | 44.5% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 13 | 15 | $5,075 | $2,798 | 55.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 50 | 55 | $4,485 | $1,978 | 44.1% |
| 12052 | Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2021 | 15 | 15 | $4,960 | $1,877 | 37.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 22 | 25 | $3,400 | $1,872 | 55.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 39 | $4,200 | $1,733 | 41.3% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 16 | 20 | $1,540 | $750.67 | 48.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $1,745 | $618.38 | 35.4% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 17 | 62 | $462.00 | $310.88 | 67.3% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2020 | 75 | 101 | $69,185 | $48,347 | 69.9% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2020 | 41 | 65 | $27,625 | $20,522 | 74.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 197 | 225 | $21,375 | $9,836 | 46.0% |
| 11104 | Punch biopsy of single skin lesion | Office | 2020 | 91 | 105 | $15,750 | $9,404 | 59.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 215 | 307 | $19,955 | $9,204 | 46.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 116 | 127 | $13,970 | $7,809 | 55.9% |
About Dr. Mark Meyers, M.D
Dr. Mark Meyers, M.D is a MOHS-Micrographic Surgery healthcare provider based in Cave Creek, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518928878.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Meyers, M.D has received a total of $312.55 in payments from pharmaceutical and medical device companies, with $36.61 received in 2024. These payments were reported across 16 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($312.55).
As a Medicare-enrolled provider, Meyers has provided services to 2,033 Medicare beneficiaries, totaling 2,597 services with total Medicare billing of $273,381. Data is available for 3 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Procedural Dermatology
- Location Cave Creek, AZ
- Active Since 03/28/2006
- Last Updated 05/02/2022
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518928878
Products in Payments
- XEOMIN (Biological) $42.75
- DUPIXENT (Biological) $36.61
- EUCRISA (Drug) $29.70
- ANORO (Drug) $29.04
- ORACEA (Drug) $29.02
- TALTZ (Drug) $26.98
- ENSTILAR (Drug) $23.68
- Erivedge (Biological) $19.95
- DUPIXENT DUPILUMAB INJECTION (Biological) $18.64
- BREO (Drug) $17.13
- Xolair (Biological) $16.35
- Ameluz (Drug) $11.43
- PICATO (Drug) $11.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.